Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Mar 14, 2019 · 10-K · 73 days after period end · 0001564590-19-007838
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Net Income | -$3.64M | -$3.74M | -$486.00K | -$1.72M |
| EPS Diluted | -$0.55 | -$3.17 | -$22.89 | $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Mar 14, 2019 · 73 d after period end
